Search research articles
Contact Us
Filters
Showing results (31-40 of 324) with videos related to
Page
of 33
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
February 26, 2003
Effect of therapeutic drug monitoring on outcome in antiretroviral experienced HIV-infected individuals
Patrick W G Mallon, John Ray, David A Cooper
The Lancet. HIV
|
October 11, 2017
Towards a universal second-line fixed-dose combination ART
Mark A Boyd, David A Cooper, Charles F Gilks
Antiviral Therapy
|
May 17, 2007
Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir
Gail V Matthews, David A Cooper, Gregory J Dore
Journal of Virology
|
August 13, 2011
Timing of the components of the HIV life cycle in productively infected CD4+ T cells in a population of HIV-infected individuals
John M Murray, Anthony D Kelleher, David A Cooper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 12, 2005
The modern ART of HIV infection management: towards a tailored approach to maximize CD4 T cell reconstitution
Sarah C Sasson, Anthony D Kelleher, David A Cooper
The Medical Journal of Australia
|
September 22, 2010
The case for boosting infant male circumcision in the face of rising heterosexual transmission of HIV
David A Cooper, Alex D Wodak, Brian J Morris
Antiviral Therapy
|
May 12, 2009
A new era of antiretroviral drug toxicity
Alexandra Calmy, Bernard Hirschel, David A Cooper, et al.
Lancet (London, England)
|
July 10, 2007
Clinical update: adverse effects of antiretroviral therapy
Alexandra Calmy, Bernard Hirschel, David A Cooper, et al.
Retrovirology
|
December 5, 2006
HIV research in Australia: linking basic research findings with clinical and public health outcomes
Sharon R Lewin, John M Kaldor, David A Cooper
AIDS (London, England)
|
April 18, 2003
Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy
Patrick W Mallon, John Miller, David A Cooper, et al.
Page
of 33
Search research articles
Search
Showing results (31-40 of 324) with videos related to
Sort By:
Page
of 33
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
February 26, 2003
Effect of therapeutic drug monitoring on outcome in antiretroviral experienced HIV-infected individuals
Patrick W G Mallon, John Ray, David A Cooper
The Lancet. HIV
|
October 11, 2017
Towards a universal second-line fixed-dose combination ART
Mark A Boyd, David A Cooper, Charles F Gilks
Antiviral Therapy
|
May 17, 2007
Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir
Gail V Matthews, David A Cooper, Gregory J Dore
Journal of Virology
|
August 13, 2011
Timing of the components of the HIV life cycle in productively infected CD4+ T cells in a population of HIV-infected individuals
John M Murray, Anthony D Kelleher, David A Cooper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 12, 2005
The modern ART of HIV infection management: towards a tailored approach to maximize CD4 T cell reconstitution
Sarah C Sasson, Anthony D Kelleher, David A Cooper
The Medical Journal of Australia
|
September 22, 2010
The case for boosting infant male circumcision in the face of rising heterosexual transmission of HIV
David A Cooper, Alex D Wodak, Brian J Morris
Antiviral Therapy
|
May 12, 2009
A new era of antiretroviral drug toxicity
Alexandra Calmy, Bernard Hirschel, David A Cooper, et al.
Lancet (London, England)
|
July 10, 2007
Clinical update: adverse effects of antiretroviral therapy
Alexandra Calmy, Bernard Hirschel, David A Cooper, et al.
Retrovirology
|
December 5, 2006
HIV research in Australia: linking basic research findings with clinical and public health outcomes
Sharon R Lewin, John M Kaldor, David A Cooper
AIDS (London, England)
|
April 18, 2003
Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy
Patrick W Mallon, John Miller, David A Cooper, et al.
Page
of 33